Search

Author/Creator Hardt, Karin

1. 656Immunogenicity and Safety Evaluation of a New Syringe Presentation of Reduced Antigen Content Diphtheria-Tetanus-Acellular Pertussis Vaccine in Healthy Adolescents: Results from a Randomized Trial. (December 2014)

Authors:
De La O, Manuel; Abarca, Katia; Lepetic, Alejandro; Hardt, Karin; Jayadeva, Girish; Kuriyakose, Sherine; Han, Htay Htay; Pavia-Ruz, Noris
Journal:
Open forum infectious diseases
Issue:
Volume 1(2014)Supplement 1
Page Start:
S184
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Efficacy, safety, and immunogenicity of a booster regimen of Ad26.COV2.S vaccine against COVID-19 (ENSEMBLE2): results of a randomised, double-blind, placebo-controlled, phase 3 trial. Issue 12 (December 2022)

Authors:
Hardt, Karin; Vandebosch, An; Sadoff, Jerald; Le Gars, Mathieu; Truyers, Carla; Lowson, David; Van Dromme, Ilse; Vingerhoets, Johan; Kamphuis, Tobias; Scheper, Gert; Ruiz-Guiñazú, Javier; Faust, Saul N; Spinner, Christoph D; Schuitemaker, Hanneke; Van Hoof, Johan; Douoguih, Macaya; Struyf, Frank;...
Journal:
Lancet infectious diseases
Issue:
Volume 22:Issue 12(2022)
Page Start:
1703
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Efficacy, safety, and immunogenicity of the human papillomavirus 16/18 AS04-adjuvanted vaccine in women older than 25 years: 7-year follow-up of the phase 3, double-blind, randomised controlled VIVIANE study. Issue 10 (October 2016)

Authors:
Wheeler, Cosette M; Skinner, S Rachel; Del Rosario-Raymundo, M Rowena; Garland, Suzanne M; Chatterjee, Archana; Lazcano-Ponce, Eduardo; Salmerón, Jorge; McNeil, Shelly; Stapleton, Jack T; Bouchard, Céline; Martens, Mark G; Money, Deborah M; Quek, Swee Chong; Romanowski, Barbara; Vallejos, Carlos ...
Journal:
Lancet infectious diseases
Issue:
Volume 16:Issue 10(2016:Oct.)
Page Start:
1154
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Efficacy, safety, and immunogenicity of the human papillomavirus 16/18 AS04-adjuvanted vaccine in women older than 25 years: 7-year follow-up of the phase 3, double-blind, randomised controlled VIVIANE study. Issue 10 (October 2016)

Authors:
Wheeler, Cosette M; Skinner, S Rachel; Del Rosario-Raymundo, M Rowena; Garland, Suzanne M; Chatterjee, Archana; Lazcano-Ponce, Eduardo; Salmerón, Jorge; McNeil, Shelly; Stapleton, Jack T; Bouchard, Céline; Martens, Mark G; Money, Deborah M; Quek, Swee Chong; Romanowski, Barbara; Vallejos, Carlos ...
Journal:
Lancet infectious diseases
Issue:
Volume 16:Issue 10(2016:Oct.)
Page Start:
1154
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Immunogenicity and reactogenicity of a decennial booster dose of a combined reduced-antigen-content diphtheria–tetanus–acellular pertussis and inactivated poliovirus booster vaccine (dTpa–IPV) in healthy adults. Issue 22 (21st May 2015)

Authors:
Kovac, Martina; Rathi, Niraj; Kuriyakose, Sherine; Hardt, Karin; Schwarz, Tino F.
Journal:
Vaccine
Issue:
Volume 33:Issue 22(2015)
Page Start:
2594
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Immunogenicity and reactogenicity of a decennial booster dose of a combined reduced-antigen-content diphtheria–tetanus–acellular pertussis and inactivated poliovirus booster vaccine (dTpa–IPV) in healthy adults. Issue 22 (21st May 2015)

Authors:
Kovac, Martina; Rathi, Niraj; Kuriyakose, Sherine; Hardt, Karin; Schwarz, Tino F.
Journal:
Vaccine
Issue:
Volume 33:Issue 22(2015)
Page Start:
2594
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Lasting immune memory against hepatitis B following challenge 10–11 years after primary vaccination with either three doses of hexavalent DTPa-HBV-IPV/Hib or monovalent hepatitis B vaccine at 3, 5 and 11–12 months of age. Issue 23 (28th May 2015)

Authors:
Avdicova, Mária; Crasta, Priya D.; Hardt, Karin; Kovac, Martina
Journal:
Vaccine
Issue:
Volume 33:Issue 23(2015)
Page Start:
2727
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Primary and booster vaccination with an inactivated poliovirus vaccine (IPV) is immunogenic and well-tolerated in infants and toddlers in China. Issue 12 (14th March 2016)

Authors:
Li, Rongcheng; Li, Chang Gui; Li, Yanping; Liu, Youping; Zhao, Hong; Chen, Xiaoling; Kuriyakose, Sherine; Van Der Meeren, Olivier; Hardt, Karin; Hezareh, Marjan; Roy-Ghanta, Sumita
Journal:
Vaccine
Issue:
Volume 34:Issue 12(2016)
Page Start:
1436
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗